---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-109824"
form_type: "8-K"
ticker: "MGTX"
cik: "0001735438"
company_name: "MeiraGTx Holdings plc"
filed_at: "2026-09-23T12:12:35+00:00"
generated_at: "2026-09-23T12:15:07.551070+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# MeiraGTx appoints Alan M. Sebulsky to Board as Class I director effective Sept 23, 2026

## Summary
- Sebulsky, Managing Member of Apothecary Capital, joins as Class I director with term expiring at 2028 annual meeting.
- Appointed to Science and Technology Committee; eligible for Non-Employee Director Compensation.
- Ex-Partner at Adage Capital for 14 years, managing a biopharma portfolio with over $2B in assets.
- Current board member of Parabilis Medicines; former director of Jazz Pharmaceuticals and Arrow International.
- CEO Alexandria Forbes cites his 25-year relationship and biopharma investing experience as valuable as company transitions to commercial.

## SEC filing metadata
- accession: 0001104659-26-109824
- form_type: 8-K
- ticker: MGTX
- cik: 0001735438
- company_name: MeiraGTx Holdings plc
- filed_at: 2026-09-23T12:12:35+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1735438/000110465926109824/0001104659-26-109824-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1735438/000110465926109824/mgtx-20260922x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-109824
- JSON: https://secwatch.observer/filing/0001104659-26-109824.json
- Plain text: https://secwatch.observer/filing/0001104659-26-109824.txt

## Key facts
- Executive change
  Alan M. Sebulsky was appointed as Class I Director at MeiraGTx Holdings plc.
  - Action: appointed
  - Role: Class I Director
  source text: appointed Alan M. Sebulsky to the Board as a Class I director, effective September 23, 2026
  evidence_url: https://www.sec.gov/Archives/edgar/data/1735438/000110465926109824/0001104659-26-109824-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.